-
2
-
-
84861874346
-
National survey of drug-resistant tuberculosis in China
-
Zhao Y, Xu S, Wang L, Chin DP, Wang S, Jiang G, et al. National survey of drug-resistant tuberculosis in China. N Engl J Med 2012; 366: 2161-70.
-
(2012)
N Engl J Med
, vol.366
, pp. 2161-2170
-
-
Zhao, Y.1
Xu, S.2
Wang, L.3
Chin, D.P.4
Wang, S.5
Jiang, G.6
-
3
-
-
33750864910
-
Extensively drug-resistant tuberculosis (XDR-TB): recommendations for prevention and control
-
Extensively drug-resistant tuberculosis (XDR-TB): recommendations for prevention and control. Wkly Epidemiol Rec 2006; 81: 430-2.
-
(2006)
Wkly Epidemiol Rec
, vol.81
, pp. 430-432
-
-
-
4
-
-
33645119729
-
Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs-worldwide, 2000-2004
-
Centers for Disease Control and Prevention (CDC). Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs-worldwide, 2000-2004. MMWR Morb Mortal Wkly Rep 2006; 55: 301-5.
-
(2006)
MMWR Morb Mortal Wkly Rep
, vol.55
, pp. 301-305
-
-
-
5
-
-
77953655525
-
Multi-drug resistant tuberculosis burden and risk factors: an update
-
Marahatta SB. Multi-drug resistant tuberculosis burden and risk factors: an update. Kathmandu Univ Med J (KUMJ) 2010; 8: 116-25.
-
(2010)
Kathmandu Univ Med J (KUMJ)
, vol.8
, pp. 116-125
-
-
Marahatta, S.B.1
-
6
-
-
77955240567
-
Extensively drug-resistant tuberculosis: epidemiology and management challenges
-
Dheda K, Warren RM, Zumla A, Grobusch MP. Extensively drug-resistant tuberculosis: epidemiology and management challenges. Infect Dis Clin North Am 2010; 24: 705-25.
-
(2010)
Infect Dis Clin North Am
, vol.24
, pp. 705-725
-
-
Dheda, K.1
Warren, R.M.2
Zumla, A.3
Grobusch, M.P.4
-
7
-
-
33749029939
-
Multidrug-resistant tuberculosis management in resource-limited settings
-
Nathanson E, Lambregts-van Weezenbeek C, Rich ML, Gupta R, Bayona J, Blondal K, et al. Multidrug-resistant tuberculosis management in resource-limited settings. Emerg Infect Dis 2006; 12: 1389-97.
-
(2006)
Emerg Infect Dis
, vol.12
, pp. 1389-1397
-
-
Nathanson, E.1
Lambregts-van Weezenbeek, C.2
Rich, M.L.3
Gupta, R.4
Bayona, J.5
Blondal, K.6
-
8
-
-
77957037450
-
-
2010 global report on surveillance and response. Geneva, Switzerland: World Health Organization
-
World Health Organization. (2010). Multidrug and extensively drug-resistant tuberculosis (M/XDR-TB). 2010 global report on surveillance and response. Geneva, Switzerland: World Health Organization.
-
(2010)
Multidrug and extensively drug-resistant tuberculosis (M/XDR-TB)
-
-
-
9
-
-
70149090840
-
The epidemiological fitness cost of drug resistance in Mycobacterium tuberculosis
-
Luciani F, Sisson SA, Jiang H, Francis AR, Tanaka MM. The epidemiological fitness cost of drug resistance in Mycobacterium tuberculosis. Proc Natl Acad Sci USA 2009; 106: 14711-15.
-
(2009)
Proc Natl Acad Sci USA
, vol.106
, pp. 14711-14715
-
-
Luciani, F.1
Sisson, S.A.2
Jiang, H.3
Francis, A.R.4
Tanaka, M.M.5
-
10
-
-
66949174024
-
Radiological findings of extensively drug-resistant pulmonary tuberculosis in non-AIDS adults: comparisons with findings of multidrug-resistant and drug-sensitive tuberculosis
-
Cha J, Lee HY, Lee KS, Koh WJ, Kwon OJ, Yi CA, et al. Radiological findings of extensively drug-resistant pulmonary tuberculosis in non-AIDS adults: comparisons with findings of multidrug-resistant and drug-sensitive tuberculosis. Korean J Radiol 2009; 10: 207-16.
-
(2009)
Korean J Radiol
, vol.10
, pp. 207-216
-
-
Cha, J.1
Lee, H.Y.2
Lee, K.S.3
Koh, W.J.4
Kwon, O.J.5
Yi, C.A.6
-
11
-
-
84860469092
-
Social behaviour risk factors for drug resistant tuberculosis in mainland China: a meta-analysis
-
Zhao P, Li XJ, Zhang SF, Wang XS, Liu CY. Social behaviour risk factors for drug resistant tuberculosis in mainland China: a meta-analysis. J Int Med Res 2012; 40: 436-45.
-
(2012)
J Int Med Res
, vol.40
, pp. 436-445
-
-
Zhao, P.1
Li, X.J.2
Zhang, S.F.3
Wang, X.S.4
Liu, C.Y.5
-
12
-
-
60849094830
-
Comparative analysis of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis-epidemiology and predictive factors
-
Vilarica AS, Gomes C, Pina J. Comparative analysis of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis-epidemiology and predictive factors. Rev Port Pneumol 2008; 14: 829-42.
-
(2008)
Rev Port Pneumol
, vol.14
, pp. 829-842
-
-
Vilarica, A.S.1
Gomes, C.2
Pina, J.3
-
13
-
-
70349817126
-
Adherence to anti-tuberculosis treatment among pulmonary tuberculosis patients: a qualitative and quantitative study
-
Xu W, Lu W, Zhou Y, Zhu L, Shen H, Wang J. Adherence to anti-tuberculosis treatment among pulmonary tuberculosis patients: a qualitative and quantitative study. BMC Health Serv Res 2009; 9: 169.
-
(2009)
BMC Health Serv Res
, vol.9
, pp. 169
-
-
Xu, W.1
Lu, W.2
Zhou, Y.3
Zhu, L.4
Shen, H.5
Wang, J.6
-
14
-
-
45349090112
-
DOT in rural China: experience from a case study in Shandong Province, China
-
Sun Q, Meng Q, Yip W, Yin X, Li H. DOT in rural China: experience from a case study in Shandong Province, China. Int J Tuberc Lung Dis 2008; 12: 625-30.
-
(2008)
Int J Tuberc Lung Dis
, vol.12
, pp. 625-630
-
-
Sun, Q.1
Meng, Q.2
Yip, W.3
Yin, X.4
Li, H.5
-
15
-
-
53949095828
-
Barriers to accessing TB diagnosis for rural-to-urban migrants with chronic cough in Chongqing, China: a mixed methods study
-
Long Q, Li Y, Wang Y, Yue Y, Tang C, Tang S, et al. Barriers to accessing TB diagnosis for rural-to-urban migrants with chronic cough in Chongqing, China: a mixed methods study. BMC Health Serv Res 2008; 8: 202.
-
(2008)
BMC Health Serv Res
, vol.8
, pp. 202
-
-
Long, Q.1
Li, Y.2
Wang, Y.3
Yue, Y.4
Tang, C.5
Tang, S.6
-
16
-
-
43949110267
-
Decentralising tuberculosis services from county tuberculosis dispensaries to township hospitals in China: an intervention study
-
Wei X, Liang X, Liu F, Walley JD, Dong B. Decentralising tuberculosis services from county tuberculosis dispensaries to township hospitals in China: an intervention study. Int J Tuberc Lung Dis 2008; 12: 538-47.
-
(2008)
Int J Tuberc Lung Dis
, vol.12
, pp. 538-547
-
-
Wei, X.1
Liang, X.2
Liu, F.3
Walley, J.D.4
Dong, B.5
-
17
-
-
83455186284
-
Treatment adherence among sputum smear-positive pulmonary tuberculosis patients in mountainous areas in China
-
Yao S, Huang WH, van den Hof S, Yang SM, Wang XL, Chen W, et al. Treatment adherence among sputum smear-positive pulmonary tuberculosis patients in mountainous areas in China. BMC Health Serv Res 2011; 11: 341.
-
(2011)
BMC Health Serv Res
, vol.11
, pp. 341
-
-
Yao, S.1
Huang, W.H.2
van den Hof, S.3
Yang, S.M.4
Wang, X.L.5
Chen, W.6
-
18
-
-
37549042773
-
Direct observation and adherence to tuberculosis treatment in Chongqing, China: a descriptive study
-
Hu D, Liu X, Chen J, Wang Y, Wang T, Zeng W, et al. Direct observation and adherence to tuberculosis treatment in Chongqing, China: a descriptive study. Health Policy Plan 2008; 23: 43-55.
-
(2008)
Health Policy Plan
, vol.23
, pp. 43-55
-
-
Hu, D.1
Liu, X.2
Chen, J.3
Wang, Y.4
Wang, T.5
Zeng, W.6
-
19
-
-
79955781618
-
For tuberculosis elimination, directly observed therapy, short course (DOTS) is essential but not sufficient
-
Fanning A. For tuberculosis elimination, directly observed therapy, short course (DOTS) is essential but not sufficient. Int J Circumpolar Health 2011; 70: 106-8.
-
(2011)
Int J Circumpolar Health
, vol.70
, pp. 106-108
-
-
Fanning, A.1
-
20
-
-
33644995903
-
Progress of DOTS in global tuberculosis control
-
Sharma SK, Liu JJ. Progress of DOTS in global tuberculosis control. Lancet 2006; 367: 951-2.
-
(2006)
Lancet
, vol.367
, pp. 951-952
-
-
Sharma, S.K.1
Liu, J.J.2
-
21
-
-
47549102958
-
Initial drug resistance and tuberculosis treatment outcomes: systematic review and meta-analysis
-
Lew W, Pai M, Oxlade O, Martin D, Menzies D. Initial drug resistance and tuberculosis treatment outcomes: systematic review and meta-analysis. Ann Intern Med 2008; 149: 123-34.
-
(2008)
Ann Intern Med
, vol.149
, pp. 123-134
-
-
Lew, W.1
Pai, M.2
Oxlade, O.3
Martin, D.4
Menzies, D.5
-
22
-
-
84875421710
-
Drug resistance in Mexico: results from the National Survey on Drug-Resistant Tuberculosis
-
Bojorquez-Chapela I, Backer CE, Orejel I, Lopez A, Diaz-Quinonez A, Hernandez-Serrato MI, et al. Drug resistance in Mexico: results from the National Survey on Drug-Resistant Tuberculosis. Int J Tuberc Lung Dis 2013; 17: 514-19.
-
(2013)
Int J Tuberc Lung Dis
, vol.17
, pp. 514-519
-
-
Bojorquez-Chapela, I.1
Backer, C.E.2
Orejel, I.3
Lopez, A.4
Diaz-Quinonez, A.5
Hernandez-Serrato, M.I.6
-
23
-
-
59349097217
-
Prevalence of tuberculosis drug resistance in 10 provinces of China
-
He GX, Zhao YL, Jiang GL, Liu YH, Xia H, Wang SF, et al. Prevalence of tuberculosis drug resistance in 10 provinces of China. BMC Infect Dis 2008; 8: 166.
-
(2008)
BMC Infect Dis
, vol.8
, pp. 166
-
-
He, G.X.1
Zhao, Y.L.2
Jiang, G.L.3
Liu, Y.H.4
Xia, H.5
Wang, S.F.6
-
24
-
-
84876122461
-
Selected culture and drug-susceptibility testing methods for drugresistant Mycobacterium tuberculosis screening in resourceconstrained settings
-
Ausina Ruiz V, Fernandez-Rivas G, Vilaplana Messeguer C. Selected culture and drug-susceptibility testing methods for drugresistant Mycobacterium tuberculosis screening in resourceconstrained settings. Expert Rev Mol Diagn 2013; 13: 247-9.
-
(2013)
Expert Rev Mol Diagn
, vol.13
, pp. 247-249
-
-
Ausina Ruiz, V.1
Fernandez-Rivas, G.2
Vilaplana Messeguer, C.3
-
25
-
-
84875602728
-
Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test
-
Lawn SD, Mwaba P, Bates M, Piatek A, Alexander H, Marais BJ, et al. Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test. Lancet Infect Dis 2013; 13: 349-61.
-
(2013)
Lancet Infect Dis
, vol.13
, pp. 349-361
-
-
Lawn, S.D.1
Mwaba, P.2
Bates, M.3
Piatek, A.4
Alexander, H.5
Marais, B.J.6
-
26
-
-
80053067126
-
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
-
Falzon D, Jaramillo E, Schunemann HJ, Arentz M, Bauer M, Bayona J, et al. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J 2011; 38: 516-28.
-
(2011)
Eur Respir J
, vol.38
, pp. 516-528
-
-
Falzon, D.1
Jaramillo, E.2
Schunemann, H.J.3
Arentz, M.4
Bauer, M.5
Bayona, J.6
-
27
-
-
77953629601
-
Availability of second-line drugs and anti-tuberculosis drug susceptibility testing in China: a situational analysis
-
He GX, van den Hof S, Borgdorff MW, van der Werf MJ, Cheng SM, Hu YL, et al. Availability of second-line drugs and anti-tuberculosis drug susceptibility testing in China: a situational analysis. Int J Tuberc Lung Dis 2010; 14: 884-9.
-
(2010)
Int J Tuberc Lung Dis
, vol.14
, pp. 884-889
-
-
He, G.X.1
van den Hof, S.2
Borgdorff, M.W.3
van der Werf, M.J.4
Cheng, S.M.5
Hu, Y.L.6
-
28
-
-
84930274566
-
China-Japan cooperation project on second-line tuberculosis drug resistance survey in Henan Province
-
Zhang G, Du C, Kurasawa T, Ikeda X, Wang W, Shi R, et al. China-Japan cooperation project on second-line tuberculosis drug resistance survey in Henan Province. J Med Forum 2005; 26: 14-16.
-
(2005)
J Med Forum
, vol.26
, pp. 14-16
-
-
Zhang, G.1
Du, C.2
Kurasawa, T.3
Ikeda, X.4
Wang, W.5
Shi, R.6
-
29
-
-
2942574537
-
Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, after the implementation of DOTS-plus, 1995-2002
-
Kam KM, Yip CW. Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, after the implementation of DOTS-plus, 1995-2002. Int J Tuberc Lung Dis 2004; 8: 760-6.
-
(2004)
Int J Tuberc Lung Dis
, vol.8
, pp. 760-766
-
-
Kam, K.M.1
Yip, C.W.2
-
30
-
-
84880278957
-
Prevalence and genetic characterization of second-line drug-resistant and extensively drug-resistant Mycobacterium tuberculosis in Rural China
-
Hu Y, Hoffner S, Wu L, Zhao Q, JiangW, Xu B. Prevalence and genetic characterization of second-line drug-resistant and extensively drug-resistant Mycobacterium tuberculosis in Rural China. Antimicrob Agents Chemother 2013; 57: 3857-63.
-
(2013)
Antimicrob Agents Chemother
, vol.57
, pp. 3857-3863
-
-
Hu, Y.1
Hoffner, S.2
Wu, L.3
Zhao, Q.4
Jiang, W.5
Xu, B.6
|